Impact of exocrine insufficiency of pancreas and supplementation of pancreatic digestive enzymes on nonalcoholic fatty liver disease (REMOTE study)
Not Applicable
- Conditions
- Before starting enrollment
- Registration Number
- JPRN-UMIN000026825
- Lead Sponsor
- onuma Institute of Community Medicine, Niigata Medical and Dental Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1) HBV positive 2) HCV positive including a SVR12 case 3) Alcohol consumption more than 20g/day 4) An organic diseases of pancreas or a past History of chronic pancreatitis 5) Allergy against porcine proteins 6) Already taking pancrelipase 7) Taking a medication for diabetes mellitus or HbA1c is 8 or higher 8) Serum triglyceride concentration is 1000 mg/dl or higher 9) Other serious conditions judged to be inadequate by a responsible doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ltrasound findings for fatty liver 24 weeks after the enrollment
- Secondary Outcome Measures
Name Time Method Shear wave velocity of the liver evoked by acoustic radiation force impulse